news
Blood test detects early stages of Alzheimer’s disease
Scientists have developed and validated a blood test for Alzheimer’s disease, with the potential to massively ramp up the pace of Alzheimer’s disease drug trials...
List view / Grid view
Kyoto University
news
Next-generation drug testing on chips
Researchers in Japan have designed a small 'body-on-a-chip' device that can test the side effects of drugs on human cells...
news
Lonza awarded contract to generate clinical grade iPSCs by the NIH CRM
The National Institutes of Health Center for Regenerative Medicine (NIH CRM) has awarded Lonza Walkersville, Inc. a contract to generate induced pluripotent stem cells (iPSCs) under current Good Manufacturing Practices (cGMP). The production of clinical grade iPSCs is considered a critical component to realizing the therapeutic potential of pluripotent stem…
news
Lonza announces license agreement with iPS Academia Japan
Lonza has entered a worldwide, non-exclusive licensing agreement with iPS Academia Japan, Inc. for its induced pluripotent stem cell (iPSC) patent portfolio. By entering this agreement, Lonza demonstrates its commitment to the field of regenerative medicine and reinforces its belief that iPSCs are a key platform technology for the cell…
